PURE Bioscienc…
ProfileJobs

PURE Bioscience

Suggest Edit
    • Manufacturing & Industrialchemicals

    PURE Bioscience, Inc. is focused on developing and commercializing proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. PURE Bioscience technology platform is based on patented, stabilized ionic silver, and initial products contain Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. The Company currently manufactures and distributes SDC-based disinfecting and sanitizing products, which are registered by the United States Environmental Protection Agency. PURE Bioscience also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products.

    Total Funding
    $1.3 M
    TypePrivate
    HQEl Cajon, US
    Founded1992
    Size (employees)36 (est)+3%
    Websitepurebio.com
    PURE Bioscience was founded in 1992 and is headquartered in El Cajon, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    PURE Bioscience Office Locations

    PURE Bioscience has an office in El Cajon
    El Cajon, US (HQ)
    1725 Gillespie Way
    Show all (1)
    Report incorrect company information

    PURE Bioscience Financials and Metrics

    Summary Metrics

    Founding Date

    		1992

    PURE Bioscience total Funding

    		$1.3 m

    PURE Bioscience latest funding size

    		$1.27 m

    Time since last funding

    		2 years ago
    PURE Bioscience's latest funding round in May 2016 was reported to be $1.3 m. In total, PURE Bioscience has raised $1.3 m
    Show all financial metrics

    PURE Bioscience Revenue

    USD

    Net income (Q3, 2018)

    		(6.1m)

    EBIT (Q3, 2018)

    		(5.7m)

    Cash (30-Apr-2018)

    		1.0m
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cost of goods sold

    		565.0k344.0k285.0k441.0k760.0k

    General and administrative expense

    		5.7m5.1m4.9m5.1m

    R&D expense

    		1.3m1.0m790.0k927.0k

    Operating expense total

    		7.0m6.1m5.7m6.0m
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Cost of goods sold

    		45.0k111.0k65.0k54.0k48.0k116.0k265.0k134.0k132.0k146.0k307.0k473.0k

    General and administrative expense

    		1.2m1.2m1.2m1.1m1.4m1.4m1.3m1.3m1.3m1.4m2.9m4.1m

    R&D expense

    		176.0k215.0k171.0k236.0k238.0k205.0k248.0k214.0k222.0k144.0k264.0k381.0k

    Operating expense total

    		1.4m1.4m1.4m1.3m1.6m1.6m1.6m1.5m1.5m2.4m4.8m6.9m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		32.0k86.0k1.3m5.2m1.6m

    Accounts Receivable

    		18.0k47.0k189.0k263.0k297.0k

    Inventories

    		350.0k27.0k

    Current Assets

    		486.0k478.0k2.0m6.1m2.5m
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Cash

    		5.3m3.9m2.5m6.1m6.7m5.4m4.1m3.9m2.7m3.2m2.1m1.0m

    Accounts Receivable

    		47.0k40.0k86.0k93.0k106.0k68.0k146.0k142.0k185.0k143.0k146.0k192.0k

    Inventories

    		231.0k186.0k207.0k219.0k237.0k320.0k348.0k340.0k348.0k274.0k267.0k275.0k

    Current Assets

    		5.8m4.2m2.9m6.6m7.2m6.2m5.0m4.6m3.5m3.9m2.7m1.6m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		(7.7m)(11.0m)(7.6m)(14.4m)(6.3m)

    Depreciation and Amortization

    		311.0k248.0k219.0k

    Inventories

    		149.0k(12.0k)(143.0k)27.0k

    Accounts Payable

    		560.0k426.0k
    Quarterly
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

    Net Income

    		(1.9m)(1.7m)(2.1m)(2.8m)(10.9m)30.0k(1.7m)(936.0k)(1.7m)(2.3m)(4.4m)(6.1m)

    Depreciation and Amortization

    		71.0k142.0k213.0k

    Inventories

    		(1.0k)(20.0k)17.0k

    Accounts Payable

    		510.0k510.0k533.0k384.0k582.0k522.0k654.0k424.0k574.0k(38.0k)7.0k(52.0k)
    show all
    USDY, 2018

    Financial Leverage

    		1.3 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Lincolnway Energy
    Energy & Utilities - Private
    Greenwell Solutions
    Energy & Utilities - Private
    BlueFire Renewables
    Energy & Utilities - Public
    Zak Products
    Automotive & Transportation - Private
    Compare competitors

    PURE Bioscience Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    PURE Bioscience News and Updates

    June 13, 2018

    PURE Bioscience, Inc. (PURE) CEO Hank Lambert on Q3 2018 Results - Earnings Call Transcript

    Report incorrect company information

    PURE Bioscience Company Life and Culture

    Report incorrect company information
    Download PDF